What ZAVA does

ZAVA is a pan-European direct-to-consumer telehealth platform founded in 2011 (originally as DrEd) and headquartered in Dublin, Ireland, with a UK regional office in London. The company serves individual patients across five European markets — the United Kingdom, Germany, France, Ireland, and Spain — by enabling online medical consultations via digital questionnaires that are reviewed by licensed, in-country physicians who issue digital prescriptions. Prescriptions are fulfilled either through a network of partner pharmacies (including 6,500 partner pharmacies in Germany) or via home delivery (Royal Mail in the UK, DHL in Germany), with typical doctor review times of under two hours in some markets. The platform is regulated by the UK GPhC and CQC, the Irish Medical Council, and corresponding authorities in Germany, France, and Spain, and holds LegitScript and ISO 27001 certifications.

ZAVA's product portfolio spans men's health (erectile dysfunction treatments such as Sildenafil and Tadalafil, hair loss treatments including Finasteride and Minoxidil, premature ejaculation), women's health and contraception (55+ contraceptive pill options, emergency contraception, bacterial vaginosis, cystitis, hormone replacement therapy), weight management (GLP-1 programs including Wegovy and Mounjaro with 200,000+ UK patients treated), sexual health (STI test kits and treatment for chlamydia, gonorrhoea, HIV, and herpes), chronic conditions (asthma, type 2 diabetes, cholesterol, hypertension, migraine, psoriasis), dermatology, fertility testing, and travel health (malaria prophylaxis, jet lag, traveler's diarrhea). Since inception, the platform has delivered 15+ million treatments and 7+ million consultations, with 1.3 million active customers and 2.3 million consultations completed in 2024.

ZAVA operates a pure direct-to-consumer transaction-based revenue model: patients pay per-consultation treatment fees (€12.90-€29.99 depending on country and treatment category) plus the cost of prescribed medication. The company is wholly owned by Hims & Hers Health, Inc. (NYSE:HIMS) following an all-cash acquisition announced in June 2025, which positioned ZAVA as the parent company's European platform for international expansion. Marketing is primarily organic — SEO, content marketing through physician-reviewed health articles, and patient referral — with regulatory exposure illustrated by the 2025 UK Advertising Standards Authority enforcement action banning affiliate-driven promotion of ZAVA's prescription weight-loss medicines.

Name

ZAVA

Legal name

ZAVA

Website

https://www.zavamed.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

101–250 employees

Short description

ZAVA is a pan-European direct-to-consumer telehealth platform founded in 2011, serving 1.3 million active patients across the UK, Germany, France, Ireland, and Spain with online doctor consultations, digital prescriptions, and medication delivery across 40+ conditions.

Ownership category

akta.pro rank

Product category

Online Telehealth Services

NAICS

Offices of Physicians (6211), Medical and Diagnostic Laboratories (62151)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)

akta.pro secondary industries

Men’s Health Prescribing + Pharmacy Delivery Platforms (HLALAIAJ), Sexual & Pelvic Health Telehealth (STI care, pelvic pain, endometriosis/PCOS support) (HLALAHAJ)

Keywords

• Online doctor consultations
• Digital prescription services
• Telehealth platform
• Weight loss treatments
• Sexual health services

Headquarters

HQ city

Dublin

HQ country

Ireland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Online Consultation and Prescription Services: ZAVA generates revenue through direct-to-consumer online medical consultations where patients pay for a medical review and prescription service. The model is transaction-based with consultation fees plus medication costs. Services cover erectile dysfunction, hair loss, contraception, weight loss, and general health conditions.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels3 records

Core offering

ZAVA is a pan-European digital health platform that enables patients to consult licensed physicians online, receive diagnoses, and obtain prescriptions without face-to-face appointments. Patients complete a medical questionnaire, have it reviewed by a doctor, and receive digital prescriptions valid at local pharmacies or delivered to their home. The platform covers more than 40 conditions across men's health, women's health, sexual health, weight management, dermatology, and chronic conditions across the UK, Germany, France, Ireland, and Spain.

Product overview

ZAVA is a multi-country European digital health platform offering online doctor consultations and prescription services. The platform operates across Germany, France, Spain, Ireland, and the United Kingdom, providing treatments across men's health (erectile dysfunction, hair loss, premature ejaculation), women's health and contraception (55+ contraceptive options), weight loss (GLP-1 programs with Wegovy/Mounjaro), sexual health (STI testing and treatment), general health (asthma, diabetes, cholesterol, hypertension), skin conditions, and travel health. Patients complete a medical questionnaire online, receive doctor review, and obtain digital prescriptions for delivery or pharmacy pickup. The platform has completed over 15 million consultations since 2011.

Differentiator

Problem solved

Functional benefit

Products and services

• Online Doctor Consultation Platform Digital health platform enabling patients to consult licensed doctors via online medical questionnaires, receive diagnoses, and obtain prescriptions without in-person visits, with pharmacy pickup or home delivery.
• Men's Health Treatments
• Women's Health and Contraception Online prescription services for women's health including more than 55 contraceptive pill options, contraceptive rings, emergency contraception, bacterial vaginosis, cystitis, hormone replacement therapy, period delay, and thrush treatment.
• Weight Loss Treatment Program Doctor-supervised weight loss program offering GLP-1 agonists and other weight management medications including Wegovy and Mounjaro, with eligibility assessment based on BMI and medical history, ongoing clinical support, and follow-up.
• Sexual Health Services Online diagnosis, treatment, and home test kits for sexually transmitted infections including Chlamydia, Gonorrhoea, genital herpes, genital warts, trichomoniasis, HIV, Syphilis, and Hepatitis, with photo-based diagnosis and postal sample collection.
• General Health and Chronic Conditions Online prescription renewals and treatments for chronic and general conditions including asthma, COPD, high blood pressure, type 2 diabetes, elevated cholesterol, migraine, psoriasis, hay fever, hyperhidrosis, smoking cessation, vitamin D deficiency, and heartburn.
• Fertility Testing Male and female fertility test kits for home use, enabling patients to check hormone levels and reproductive health markers without visiting a clinic.
• Skin Conditions Treatment Online dermatology consultations and prescriptions for skin conditions including acne, eczema, rosacea, cold sores, perioral dermatitis, and psoriasis, with photo-based diagnosis available.
• Travel Health Services Online prescriptions for travel-related medications including malaria prophylaxis tablets, jet lag treatment, and traveler's diarrhoea medication.

Quantifiable outcome

• 15+ million treatments delivered since 2011
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Hims & Hers HealthcoreStrategic or Co-development Partner · 3 June 2025Hims & Hers Health acquired ZAVA in an all-cash transaction to expand into European markets including UK, Germany, France, and Ireland. The acquisition was expected to close in H2 2025 and become accretive by 2026. ZAVA's 1.3 million active customers and 2.3 million consultations in 2024 supported Hims & Hers' international growth strategy.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Hims & Hers Health: NYSE-listed D2C telehealth platform offering prescription-based treatments for men's health, women's health, hair loss, weight loss, and mental health. ZAVA's parent company since 2025; closest direct competitor in business model and condition verticals, with US-focused execution.
• MedExpress: UK-based online pharmacy and telehealth provider offering prescription medications and weight-loss treatments. Co-named with ZAVA in ASA advertising enforcement actions, indicating overlapping product mix and target customers in the British D2C telehealth market.
• Numan: UK-based D2C men's health telehealth platform specializing in ED, hair loss, and weight loss. Directly competes with ZAVA in the UK on men's health conditions with similar online consultation + pharmacy delivery model.
• Voy: UK online weight-loss clinic offering GLP-1 prescriptions. Co-named with ZAVA in ASA enforcement actions and directly competes in the UK weight-loss/GLP-1 vertical with similar digital consultation and home delivery model.
• Treated: UK-based online pharmacy and telehealth provider offering prescription medications across men's health, women's health, and chronic conditions. Directly comparable D2C model and product portfolio to ZAVA in the UK and EU markets.
• UK Meds Direct: UK-based online pharmacy platform offering prescription medications including weight-loss treatments. Co-named with ZAVA in ASA enforcement; similar D2C model targeting UK patients seeking prescription medications without GP visits.

Emerging players

• Ro (Roman): US-based D2C telehealth platform offering prescription treatments for men's health, weight loss, and chronic conditions. Closely mirrors ZAVA's condition-specific Rx model but operates in the US market; relevant as a comparable business model reference.

Regional players

• Push Doctor: UK-based online GP consultation platform offering video appointments and prescriptions. Comparable business model in the UK market but focuses on general practice consultations rather than condition-specific Rx verticals like ZAVA.
• Doctolib: France-based dominant healthcare booking and telehealth platform. While primarily an appointment-booking platform, Doctolib has expanded into video consultations and prescription services in France, overlapping with ZAVA's French market positioning.
• Kry / Livi: Swedish-origin digital healthcare platform operating across UK, France, Germany, and Nordics. Comparable pan-European telehealth footprint to ZAVA, though focused primarily on NHS/private GP video appointments rather than Rx-led condition-specific prescribing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/zavamed
• Facebookfacebook.com/ZavaUK
• LinkedInlinkedin.com/company/zava-med

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ZAVA